[Withdrawal symptoms in a neonate following exposure to venlafaxine during pregnancy].
Bloem
B R
BR
Roofthooft
D W
DW
Lammers
G J
GJ
de Beaufort
A J
AJ
Brouwer
O F
OF
D018687:Antidepressive Agents, Second-Generation / Q000008:administration & dosage / Q000009:adverse effects*; D003511:Cyclohexanols / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D009357:Neonatal Abstinence Syndrome / Q000175:diagnosis*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy; D000069470:Venlafaxine Hydrochloride
D018687:Antidepressive Agents, Second-Generation; D003511:Cyclohexanols; D000069470:Venlafaxine Hydrochloride